Algert Global’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86M | Buy |
149,579
+93,400
| +166% | +$3.04M | 0.1% | 340 |
|
|
2025
Q1 | $2.12M | Sell |
56,179
-16,890
| -23% | -$638K | 0.05% | 584 |
|
|
2024
Q4 | $5.98M | Buy |
73,069
+33,777
| +86% | +$2.76M | 0.14% | 225 |
|
|
2024
Q3 | $4.49M | Buy |
39,292
+4,540
| +13% | +$519K | 0.12% | 289 |
|
|
2024
Q2 | $2.62M | Buy |
34,752
+21,442
| +161% | +$1.62M | 0.09% | 379 |
|
|
2024
Q1 | $909K | Sell |
13,310
-1,080
| -8% | -$73.8K | 0.04% | 637 |
|
|
2023
Q4 | $904K | Sell |
14,390
-10,400
| -42% | -$653K | 0.04% | 643 |
|
|
2023
Q3 | $1.26M | Buy |
24,790
+2,790
| +13% | +$142K | 0.06% | 513 |
|
|
2023
Q2 | $1.1M | Buy |
22,000
+163
| +0.7% | +$8.14K | 0.05% | 627 |
|
|
2023
Q1 | $818K | Buy |
+21,837
| New | +$818K | 0.04% | 703 |
|
|
2022
Q4 | – | Sell |
-45,505
| Closed | -$1.09M | – | 1243 |
|
|
2022
Q3 | $1.09M | Buy |
45,505
+16,181
| +55% | +$388K | 0.07% | 504 |
|
|
2022
Q2 | $638K | Buy |
29,324
+19,850
| +210% | +$432K | 0.05% | 674 |
|
|
2022
Q1 | $229K | Sell |
9,474
-3,292
| -26% | -$79.6K | 0.02% | 1020 |
|
|
2021
Q4 | $304K | Buy |
12,766
+1,480
| +13% | +$35.2K | 0.04% | 725 |
|
|
2021
Q3 | $286K | Buy |
+11,286
| New | +$286K | 0.04% | 780 |
|